|
1,2,3-Cyclopentanetriol, 4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[[(2R)-2-hydroxypropyl]thio]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-, (1S,2R,3S,4R)- Suppliers list
|
1,2,3-Cyclopentanetriol, 4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[[(2R)-2-hydroxypropyl]thio]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-, (1S,2R,3S,4R)- manufacturers
|
| | 1,2,3-Cyclopentanetriol, 4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[[(2R)-2-hydroxypropyl]thio]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-, (1S,2R,3S,4R)- Basic information |
| Product Name: | 1,2,3-Cyclopentanetriol, 4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[[(2R)-2-hydroxypropyl]thio]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-, (1S,2R,3S,4R)- | | Synonyms: | 1,2,3-Cyclopentanetriol, 4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[[(2R)-2-hydroxypropyl]thio]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-, (1S,2R,3S,4R)-;Antiplatelet agent 1 | | CAS: | 2493297-12-2 | | MF: | C21H24F2N6O4S | | MW: | 494.51 | | EINECS: | | | Product Categories: | | | Mol File: | 2493297-12-2.mol | ![1,2,3-Cyclopentanetriol, 4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[[(2R)-2-hydroxypropyl]thio]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-, (1S,2R,3S,4R)- Structure](CAS/20210305/GIF/2493297-12-2.gif) |
| | 1,2,3-Cyclopentanetriol, 4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[[(2R)-2-hydroxypropyl]thio]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-, (1S,2R,3S,4R)- Chemical Properties |
| Boiling point | 763.5±70.0 °C(Predicted) | | density | 1.82±0.1 g/cm3(Predicted) | | pka | 13.38±0.70(Predicted) |
| | 1,2,3-Cyclopentanetriol, 4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[[(2R)-2-hydroxypropyl]thio]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-, (1S,2R,3S,4R)- Usage And Synthesis |
| Uses | Antiplatelet agent 1 (compound 7q) is a Ticagrelor analoguehas, possessing antiplatelet activity. Antiplatelet agent 1 can be used for researching platelet aggregation[1]. | | References | [1] Goffin E, et al. Synthesis of ticagrelor analogues belonging to 1,2,3-triazolo[4,5-d]pyrimidines and study of their antiplatelet and antibacterial activity.Eur J Med Chem. 2020;208:112767. DOI:10.1016/j.ejmech.2020.112767 |
| | 1,2,3-Cyclopentanetriol, 4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-[[(2R)-2-hydroxypropyl]thio]-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-, (1S,2R,3S,4R)- Preparation Products And Raw materials |
|